VENUSREM.NS
Price:
$1788.5
Market Cap:
$23.91B
Venus Remedies Limited is a pharmaceutical enterprise engaged in the development, production, and global distribution of its medicinal products, serving both the Indian and international markets. The company's diverse portfolio addresses a wide spectrum of therapeutic areas, including treatments for pain and fever, diabetes, bacterial infections, cardiovascular conditions, gastrointestinal disorders, neurological ailments, and oncology. Additionally, it provides solutions for respiratory health, skin and wound care, stress management, and urological issues, alongside essential vitamins, minerals, and nutritional supplements. Venus Remedies is also active in the field of antimicrobial resista...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-12-20
Stock Exchange
NSE
Ticker
VENUSREM.NS
According to Venus Remedies Limited’s latest financial reports and current stock price. The company's current PE Ratio is 31.33. This represents a change of 220.97% compared to the average of 9.76 of the last 4 quarters.
The mean historical PE Ratio of Venus Remedies Limited over the last ten years is 4.47. The current 31.33 PE Ratio has changed 70.02% with respect to the historical average. Over the past ten years (40 quarters), VENUSREM.NS's PE Ratio was at its highest in in the March 2022 quarter at 375.42. The PE Ratio was at its lowest in in the December 2019 quarter at -7.18.
Average
4.47
Median
6.83
Minimum
-6.56
Maximum
15.88
Discovering the peaks and valleys of Venus Remedies Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.21%
Maximum Annual PE Ratio = 15.88
Minimum Annual Increase = -302.19%
Minimum Annual PE Ratio = -6.56
| Year | PE Ratio | Change |
|---|---|---|
| 2026 | 10.67 | 14.32% |
| 2025 | 9.33 | -41.24% |
| 2024 | 15.88 | 94.21% |
| 2023 | 8.18 | -6.66% |
| 2022 | 8.76 | 59.50% |
| 2021 | 5.49 | -302.19% |
| 2020 | -2.72 | 84.74% |
| 2019 | -1.47 | -48.72% |
| 2018 | -2.87 | -56.31% |
| 2017 | -6.56 | -111.02% |
The current PE Ratio of Venus Remedies Limited (VENUSREM.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.96
5-year avg
10.56
10-year avg
4.47
Venus Remedies Limited’s PE Ratio is greater than Kilitch Drugs (India) Limited (20.50), greater than Kilitch Drugs (India) Limited (20.50), less than Ind-Swift Laboratories Limited (44.47), less than Ind-Swift Laboratories Limited (44.47), greater than Medicamen Biotech Limited (31.26), greater than Medicamen Biotech Limited (31.26), greater than Albert David Limited (-264.96), greater than Jenburkt Pharmaceuticals Limited (13.84), less than Shree Ganesh Remedies Limited (47.05), greater than Medico Remedies Limited (24.45),
| Company | PE Ratio | Market cap |
|---|---|---|
| 20.50 | $6.52B | |
| 20.50 | $6.39B | |
| 44.47 | $20.42B | |
| 44.47 | $20.34B | |
| 31.26 | $3.23B | |
| 31.26 | $3.23B | |
| -264.96 | $3.96B | |
| 13.84 | $4.81B | |
| 47.05 | $8.35B | |
| 24.45 | $3.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Remedies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Venus Remedies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Venus Remedies Limited's PE Ratio?
How is the PE Ratio calculated for Venus Remedies Limited (VENUSREM.NS)?
What is the highest PE Ratio for Venus Remedies Limited (VENUSREM.NS)?
What is the 3-year average PE Ratio for Venus Remedies Limited (VENUSREM.NS)?
What is the 5-year average PE Ratio for Venus Remedies Limited (VENUSREM.NS)?
How does the current PE Ratio for Venus Remedies Limited (VENUSREM.NS) compare to its historical average?